Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Comprehensive Cancer Center Vienna · Medical University of Vienna · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
557
total citations
- FWCI
- 29.44
- Percentile
- 100%
- References
- 37
Citations per year
Authors
26- MGMichael GnantCorresponding
Comprehensive Cancer Center Vienna, Medical University of Vienna
- GPGeorg Pfeiler
Medical University of Vienna, Comprehensive Cancer Center Vienna
- PDPeter Dubsky
Medical University of Vienna, Comprehensive Cancer Center Vienna
- MHMichael Hubalek
Innsbruck Medical University
- RGRichard Greil
Paracelsus Medical University
Topics & keywords
Topics
Keywords
- Medicine
- Denosumab
- Breast cancer
- Clinical endpoint
- Aromatase inhibitor
- Internal medicine
- Population
- Placebo
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.